Global Biosimilars Market

Company Usability Profiles:

The global biosimilars market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The global biosimilars market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Amgen Inc.
  • Biogen Inc.
  • Dr. Reddy's Laboratories Limited
  • Mylan N.V.
  • Pfizer Inc.
  • Sandoz International GmbH
  • AMEGA Biotech S.A.
  • Apotex Inc.
  • Biogen Inc.
  • Biosidus S.A.
  • Bioton S.A.
  • Dr. Reddy's Laboratories Limited
  • Innovent Biologics, Inc.
  • JHL Biotech, Inc.
  • LG Chem, Ltd.
  • Merck Sharp & Dohme Corp.

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Market Segmentation & Coverage:

The research report categorizes the Global Biosimilars Market to forecast the revenues and analyze the trends in each of the following segments:

  • GLOBAL BIOSIMILARS MARKET, BY INDICATION
    • Autoimmune Diseases
    • Blood Disorders
    • Chronic Diseases
    • Growth Hormone Deficiency
    • Infectious Diseases
    • Oncology
  • GLOBAL BIOSIMILARS MARKET, BY PRODUCT
    • Recombinant Glycosylated Proteins
      • Erythropoietin
      • Follitropin
      • Monoclonal Antibodies
        • Adalimumab
        • Infliximab
        • Rituximab
    • Recombinant Non-Glycosylated Proteins
      • Granulocyte Colony-Stimulating Factor
      • Insulin
      • Interferons
        • Interferon-Alpha
        • Interferon-Beta
      • Recombinant Human Growth Hormone
    • Recombinant Peptides
      • Calcitonin
      • Glucagon
  • GLOBAL BIOSIMILARS MARKET, BY MANUFACTURING
    • Contract Manufacturing
    • In-House Manufacturing
  • GLOBAL BIOSIMILARS MARKET, BY GEOGRAPHY
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
    • Asia-Pacific
      • Australia
      • China
      • India
      • Japan
    • Europe, Middle East & Africa
      • France
      • Germany
      • Italy
      • Spain
      • United Kingdom

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Global Biosimilars Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Global Biosimilars Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Global Biosimilars Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Global Biosimilars Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Global Biosimilars Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Global Biosimilars Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Global Biosimilars Market .
  • Evaluate the key vendors in the Global Biosimilars Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
      1. Research Process
      2. Research Framework
      3. Research Reliability & Validity
      4. Research Assumptions
    2. Forecasting Methodology
    3. Research Outcome
      1. 360iResearch Competitive Strategic Window
        1. Leverage Zone
        2. Vantage Zone
        3. Speculative Zone
        4. Bottleneck Zone
      2. 360iResearch FPNV Positioning Matrix
        1. 360iResearch Quadrants
          1. Forefront
          2. Pathfinders
          3. Niche
          4. Vital
        2. Business Strategy
          1. Business Growth
          2. Industry Coverage
          3. Financial Viability
          4. Channel Support
        3. Product Satisfaction
          1. Value for Money
          2. Ease of Use
          3. Product Features
          4. Customer Support
  3. Executive Summary
    1. Outlook in the Biosimilars Market
      1. Since, 2006 when the first biosimilar has been introduced in the market, oncology has always remained the most focussed area for the development of biosimilars and has represented a huge impact on the treatment of cancer in multiple tumor types.
      2. The players in the Biosimilar market are working at a feverish pace to develop the next generation of follow-on products.
      3. Development of Recombinant Glycosylated Proteins category of biosimilars has always dominated the global market during the forecast period.
      4. he Biosimilar market in Europe, Middle East, And Africa represent a dominating space during the forecast period.
      5. Sandoz to resubmit biosimilar pegfilgrastim application to US FDA
      6. Merck to acquire Immune Design
    2. Opportunities in the Biosimilars Market
    3. Geographical Analysis in the Biosimilars Market
  4. Premium Insight
    1. Market Connectivity
    2. Market Dynamics
      1. Drivers
        1. Growing pressure to reduce healthcare expenditure
        2. Growing demands of pharmaceutical drugs
        3. Expiration of major patents during the forecast period
        4. Supportive government initiative and awareness creating programs in the developing economies
        5. Lower cost biosimilars drugs than original biologics
      2. Restraints
        1. Reluctance of physicians to prescribe biosimilars
        2. Unawareness among patients and preference for brand
      3. Opportunities
        1. New indications and patent expiry of biologic products
        2. Potential in emerging markets
        3. Emergence of bio-betters drugs
      4. Challenges
        1. Stringent regulatory requirements adversely affecting investment in the biosimilars market
        2. High investment required for research and development
    3. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    4. Industry Trends
      1. Technical Development & Trends
      2. Regulatory Submissions Timelines
      3. Clinical Bio Analytics and Technical Timelines and Related FTEs
      4. Drugs Loosing Patent: 2018-2022
  5. Global Biosimilars Market, by Indication
    1. Overview
    2. Market Sizing & Forecasting
    3. Autoimmune Diseases
    4. Blood Disorders
    5. Chronic Diseases
    6. Growth Hormone Deficiency
    7. Infectious Diseases
    8. Oncology
  6. Global Biosimilars Market, by Product
    1. Overview
    2. Market Sizing & Forecasting
    3. Recombinant Glycosylated Proteins
      1. Erythropoietin
      2. Follitropin
      3. Monoclonal Antibodies
        1. Adalimumab
        2. Infliximab
        3. Rituximab
    4. Recombinant Non-Glycosylated Proteins
      1. Granulocyte Colony-Stimulating Factor
      2. Insulin
      3. Interferons
        1. Interferon-Alpha
        2. Interferon-Beta
      4. Recombinant Human Growth Hormone
    5. Recombinant Peptides
      1. Calcitonin
      2. Glucagon
  7. Global Biosimilars Market, by Manufacturing
    1. Overview
    2. Market Sizing & Forecasting
    3. Contract Manufacturing
    4. In-House Manufacturing
  8. Global Biosimilars Market, by Geography
    1. Americas
      1. Overview
      2. Market Sizing & Forecasting
      3. Argentina
      4. Brazil
      5. Canada
      6. Mexico
      7. United States
    2. Asia-Pacific
      1. Overview
      2. Market Sizing & Forecasting
      3. Australia
      4. China
      5. India
      6. Japan
    3. Europe, Middle East & Africa
      1. Overview
      2. Market Sizing & Forecasting
      3. France
      4. Germany
      5. Italy
      6. Spain
      7. United Kingdom
  9. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix for Global Biosimilars Market
    2. Market Vendor Ranking Analysis for Global Biosimilars Market
    3. Competitive News Feed Analysis for Global Biosimilars Market
  10. Company Usability Profiles
    1. Amgen Inc.
      1. Overview
      2. Strategy
      3. SWOT
    2. Biogen Inc.
      1. Overview
      2. Strategy
      3. SWOT
    3. Dr. Reddy's Laboratories Limited
      1. Overview
      2. Strategy
      3. SWOT
    4. Mylan N.V.
      1. Overview
      2. Strategy
      3. SWOT
    5. Pfizer Inc.
      1. Overview
      2. Strategy
      3. SWOT
    6. Sandoz International GmbH
      1. Overview
      2. Strategy
      3. SWOT
    7. AMEGA Biotech S.A.
    8. Apotex Inc.
    9. Biogen Inc.
    10. Biosidus S.A.
    11. Bioton S.A.
    12. Dr. Reddy's Laboratories Limited
    13. Innovent Biologics, Inc.
    14. JHL Biotech, Inc.
    15. LG Chem, Ltd.
    16. Merck Sharp & Dohme Corp.
  11. Appendix
    1. Discussion Guide
    2. Top Reports
      1. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      2. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      3. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      4. Global Fitness App Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      5. Global A2P and P2A Messaging Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      6. Global PDF Editor Software Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      7. Global Innovation Management Software Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
    3. Author Details

List of Tables

  1. GLOBAL BIOSIMILARS MARKET SIZE, 2016-2025 (USD MILLION)
  2. GLOBAL BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  3. GLOBAL BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  4. GLOBAL BIOSIMILARS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  5. GLOBAL BIOSIMILARS MARKET SIZE, BY BLOOD DISORDERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  6. GLOBAL BIOSIMILARS MARKET SIZE, BY CHRONIC DISEASES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  7. GLOBAL BIOSIMILARS MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  8. GLOBAL BIOSIMILARS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  9. GLOBAL BIOSIMILARS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  10. GLOBAL BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  11. GLOBAL BIOSIMILARS MARKET SIZE, BY RECOMBINANT GLYCOSYLATED PROTEINS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  12. GLOBAL BIOSIMILARS MARKET SIZE, BY ERYTHROPOIETIN, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  13. GLOBAL BIOSIMILARS MARKET SIZE, BY FOLLITROPIN, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  14. GLOBAL BIOSIMILARS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  15. GLOBAL BIOSIMILARS MARKET SIZE, BY ADALIMUMAB, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  16. GLOBAL BIOSIMILARS MARKET SIZE, BY INFLIXIMAB, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  17. GLOBAL BIOSIMILARS MARKET SIZE, BY RITUXIMAB, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  18. GLOBAL BIOSIMILARS MARKET SIZE, BY RECOMBINANT NON-GLYCOSYLATED PROTEINS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  19. GLOBAL BIOSIMILARS MARKET SIZE, BY GRANULOCYTE COLONY-STIMULATING FACTOR, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  20. GLOBAL BIOSIMILARS MARKET SIZE, BY INSULIN, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  21. GLOBAL BIOSIMILARS MARKET SIZE, BY INTERFERONS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  22. GLOBAL BIOSIMILARS MARKET SIZE, BY INTERFERON-ALPHA, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  23. GLOBAL BIOSIMILARS MARKET SIZE, BY INTERFERON-BETA, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  24. GLOBAL BIOSIMILARS MARKET SIZE, BY RECOMBINANT HUMAN GROWTH HORMONE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  25. GLOBAL BIOSIMILARS MARKET SIZE, BY RECOMBINANT PEPTIDES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  26. GLOBAL BIOSIMILARS MARKET SIZE, BY CALCITONIN, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  27. GLOBAL BIOSIMILARS MARKET SIZE, BY GLUCAGON, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  28. GLOBAL BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  29. GLOBAL BIOSIMILARS MARKET SIZE, BY CONTRACT MANUFACTURING, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  30. GLOBAL BIOSIMILARS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  31. AMERICAS BIOSIMILARS MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  32. AMERICAS BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  33. AMERICAS BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  34. AMERICAS BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  35. ARGENTINA BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  36. ARGENTINA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  37. ARGENTINA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  38. BRAZIL BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  39. BRAZIL BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  40. BRAZIL BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  41. CANADA BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  42. CANADA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  43. CANADA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  44. MEXICO BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  45. MEXICO BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  46. MEXICO BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  47. UNITED STATES BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  48. UNITED STATES BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  49. UNITED STATES BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  50. ASIA-PACIFIC BIOSIMILARS MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  51. ASIA-PACIFIC BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  52. ASIA-PACIFIC BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  53. ASIA-PACIFIC BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  54. AUSTRALIA BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  55. AUSTRALIA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  56. AUSTRALIA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  57. CHINA BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  58. CHINA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  59. CHINA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  60. INDIA BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  61. INDIA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  62. INDIA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  63. JAPAN BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  64. JAPAN BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  65. JAPAN BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  66. EUROPE, MIDDLE EAST & AFRICA BIOSIMILARS MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  67. EUROPE, MIDDLE EAST & AFRICA BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  68. EUROPE, MIDDLE EAST & AFRICA BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  69. EUROPE, MIDDLE EAST & AFRICA BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  70. FRANCE BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  71. FRANCE BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  72. FRANCE BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  73. GERMANY BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  74. GERMANY BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  75. GERMANY BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  76. ITALY BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  77. ITALY BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  78. ITALY BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  79. SPAIN BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  80. SPAIN BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  81. SPAIN BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  82. UNITED KINGDOM BIOSIMILARS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  83. UNITED KINGDOM BIOSIMILARS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  84. UNITED KINGDOM BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2016-2025 (USD MILLION)
  85. GLOBAL BIOSIMILARS MARKET: RANKING
  86. GLOBAL BIOSIMILARS MARKET: BUSINESS STRATEGY
  87. GLOBAL BIOSIMILARS MARKET: PRODUCT SATISFACTION
  88. GLOBAL BIOSIMILARS MARKET: AUTHOR DETAILS

List of Figures

  1. Global Biosimilars Market: Research Process
  2. Global Biosimilars Market: Research Framework
  3. Global Biosimilars Market: Forecasting Methodology
  4. Global Biosimilars Market: 360iResearch Competitive Strategic Window
  5. Global Biosimilars Market: 360iResearch FPNV Positioning Matrix
  6. GLOBAL BIOSIMILARS MARKET SIZE, 2016-2025 (USD MILLION)
  7. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMILARS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  8. GLOBAL BIOSIMILARS MARKET: MARKET CONNECTIVITY
  9. PORTERS FIVE FORCES ANALYSIS FOR GLOBAL BIOSIMILARS MARKET
  10. GLOBAL BIOSIMILARS MARKET SIZE, BY INDICATION, 2018 VS 2025 (USD MILLION)
  11. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMILARS MARKET SIZE, BY INDICATION, 2025 (USD MILLION)
  12. GLOBAL BIOSIMILARS MARKET SIZE, BY PRODUCT, 2018 VS 2025 (USD MILLION)
  13. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMILARS MARKET SIZE, BY PRODUCT, 2025 (USD MILLION)
  14. GLOBAL BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2018 VS 2025 (USD MILLION)
  15. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOSIMILARS MARKET SIZE, BY MANUFACTURING, 2025 (USD MILLION)
  16. GLOBAL BIOSIMILARS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  17. AMGEN INC.: BUSINESS SWOT
  18. BIOGEN INC.: BUSINESS SWOT
  19. DR. REDDY'S LABORATORIES LIMITED: BUSINESS SWOT
  20. MYLAN N.V.: BUSINESS SWOT
  21. PFIZER INC.: BUSINESS SWOT
  22. SANDOZ INTERNATIONAL GMBH: BUSINESS SWOT
  1. Amgen Inc.
  2. Biogen Inc.
  3. Dr. Reddy's Laboratories Limited
  4. Mylan N.V.
  5. Pfizer Inc.
  6. Sandoz International GmbH
  7. AMEGA Biotech S.A.
  8. Apotex Inc.
  9. Biogen Inc.
  10. Biosidus S.A.
  11. Bioton S.A.
  12. Dr. Reddy's Laboratories Limited
  13. Innovent Biologics, Inc.
  14. JHL Biotech, Inc.
  15. LG Chem, Ltd.
  16. Merck Sharp & Dohme Corp.
360iResearch Logo
Global Biosimilars Market
Report Code: PH-17D6591 | Publishing Date: June 2019 | Number of Pages: 101
cookiefy_close